|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 5510 |
FusionGeneSummary for CAPZB_AKR7A3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CAPZB_AKR7A3 | Fusion gene ID: 5510 | Hgene | Tgene | Gene symbol | CAPZB | AKR7A3 | Gene ID | 832 | 22977 |
| Gene name | capping actin protein of muscle Z-line subunit beta | aldo-keto reductase family 7 member A3 | |
| Synonyms | CAPB|CAPPB|CAPZ | AFAR2 | |
| Cytomap | 1p36.13 | 1p36.13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | F-actin-capping protein subunit betacapZ betacapping actin protein of muscle Z-line beta subunitcapping protein (actin filament) muscle Z-line, beta | aflatoxin B1 aldehyde reductase member 3AFB1 aldehyde reductase 2AFB1-AR 2aflatoxin B1 aldehyde reductase 2aflatoxin aldehyde reductase | |
| Modification date | 20180523 | 20180527 | |
| UniProtAcc | P47756 | O95154 | |
| Ensembl transtripts involved in fusion gene | ENST00000401084, ENST00000264203, ENST00000375142, ENST00000433834, ENST00000264202, ENST00000482808, ENST00000375144, | ENST00000361640, | |
| Fusion gene scores | * DoF score | 14 X 14 X 9=1764 | 1 X 1 X 1=1 |
| # samples | 22 | 1 | |
| ** MAII score | log2(22/1764*10)=-3.00327513203286 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: CAPZB [Title/Abstract] AND AKR7A3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | LIHC | TCGA-BC-4073-01B | CAPZB | chr1 | 19811930 | - | AKR7A3 | chr1 | 19612866 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000401084 | ENST00000361640 | CAPZB | chr1 | 19811930 | - | AKR7A3 | chr1 | 19612866 | - |
| 5UTR-3CDS | ENST00000264203 | ENST00000361640 | CAPZB | chr1 | 19811930 | - | AKR7A3 | chr1 | 19612866 | - |
| Frame-shift | ENST00000375142 | ENST00000361640 | CAPZB | chr1 | 19811930 | - | AKR7A3 | chr1 | 19612866 | - |
| intron-3CDS | ENST00000433834 | ENST00000361640 | CAPZB | chr1 | 19811930 | - | AKR7A3 | chr1 | 19612866 | - |
| Frame-shift | ENST00000264202 | ENST00000361640 | CAPZB | chr1 | 19811930 | - | AKR7A3 | chr1 | 19612866 | - |
| 5UTR-3CDS | ENST00000482808 | ENST00000361640 | CAPZB | chr1 | 19811930 | - | AKR7A3 | chr1 | 19612866 | - |
| intron-3CDS | ENST00000375144 | ENST00000361640 | CAPZB | chr1 | 19811930 | - | AKR7A3 | chr1 | 19612866 | - |
Top |
FusionProtFeatures for CAPZB_AKR7A3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CAPZB | AKR7A3 |
| F-actin-capping proteins bind in a Ca(2+)-independentmanner to the fast growing ends of actin filaments (barbed end)thereby blocking the exchange of subunits at these ends. Unlikeother capping proteins (such as gelsolin and severin), theseproteins do not sever actin filaments. Plays a role in theregulation of cell morphology and cytoskeletal organization.{ECO:0000269|PubMed:21834987}. | Can reduce the dialdehyde protein-binding form ofaflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May beinvolved in protection of liver against the toxic and carcinogeniceffects of AFB1, a potent hepatocarcinogen.{ECO:0000269|PubMed:18416522}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CAPZB_AKR7A3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CAPZB_AKR7A3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| CAPZB | TWF2, MRPL20, PTN, BCCIP, UIMC1, DMWD, MEPCE, PPP2R2B, RPP14, BLNK, SP1, CD2AP, UBE2Q2, CDK2, FAM21C, ARHGAP17, LRRK2, BAG3, HSPA8, CAPZA1, ESR1, BRCA1, MDC1, PAXIP1, TP53BP1, MAGOH, EIF4A3, FN1, VCAM1, ITGA4, PAN2, VHL, FBXO6, HECW2, AHCY, CAPZA2, DCTPP1, HEXA, TUBB3, PAPSS1, TP53, HUWE1, CUL7, OBSL1, CCDC8, BMI1, SIRT6, DAPK1, MARK3, STAP1, PLEKHO2, SH3KBP1, ARPC2, ARPC3, ARPC5, ARPC5L, DCTN2, DCTN4, DLD, LRRC16A, MCFD2, PCID2, CNOT2, DCTN1, DCTN6, DDX53, MYO5B, NAPA, RPAP3, TMOD3, TOMM40, TPM2, UBL7, NTRK1, RPGRIP1L, DBN1, MARK2, FLNA, GAK, MYH9, MYH11, PPP1CB, PPP1CC, VCL, IQGAP1, PDLIM7, VPS26A, SYNPO, CNOT1, LIMA1, ANLN, MYO5C, MYO19, MYO18A, MCM2, GLI1, U2AF2, CDC73, CDH1, DUSP8, RCSD1, PLEKHO1, ACTR1B, STYX, COX15, TRIM25, TES, RNF169 | AKR7A3 | AKR7A2, AKR7A3, TERF2IP, BAG3, AKR7L, COMMD9, GNB2, TRMT11, DDRGK1, C20orf195 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CAPZB_AKR7A3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CAPZB_AKR7A3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CAPZB | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
| Hgene | CAPZB | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
| Hgene | CAPZB | C0948089 | Acute Coronary Syndrome | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|